The AMR Briefing Sessions 24–26 August 2021, is running digitally each day from 2:00 p.m. to 4:30 p.m. CEST.
Each day will offer digitally delivered AMR Briefing Sessions starting at 2pm with live speakers, high-level panel discussions and interactive exchange. Participation will be offered free of charge.
> Day 1 – Status quo & COVID-19 Impact
Speakers: David Barros-Aguirre (GSK), Justin Yang (BARDA Ventures), Janet Hemingway (iiCON), Marco Cavaleri (EMA), Jessica Boname (MRC/JPI AMR), Jürgen Popp (Leibniz-IPHT), Philippe Villain-Guillot (Nosopharm), Christoph Dehio (University of Basel)
> Day 2 – Financing & Investing
Speakers: Henry Skinner (AMR Action Fund), Aleks Engel (Novo Repair Impact Fund), Marc Gitzinger (BioVersys), David P. Luci (Acurx Pharmaceuticals), Peter Jackson (Infex Therapeutics), Erin Duffy (CARB-X), Douglas Häggström (INCATE/University of Basel), Anders Karlén (University of Uppsala/IMI AMR Accelerator), Igor Orshanskiy (AiCubator)
> Day 3 – Policy & Incentives
Speakers: Kathy Talkington (Pew Charitable Trust), Kevin Outterson (CARB-X), David Glover (NHS England), Colm Leonard (NICE), Caline Mattar (Washington University), Enrico Baraldi (University of Uppsala), Peter Beyer (WHO), Thomas Cueni (IFPMA), Isabelle Bekeredjian-Ding (PEI), Greg Frank (MSD/AMR Industry Alliance)
More information here
